Perioperative Fluid Management According to the Preoperative and Perioperative Glucose Level
NCT ID: NCT03955237
Last Updated: 2019-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
250 participants
INTERVENTIONAL
2015-01-31
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: The aim of this prospective study is to evaluate the different glucose concentrations(without dextrose, 1 % dextrose+LR, 2 % dextrose+LR) in perioperative infusion solutions according to preoperative blood glucose level to maintain normoglycemia in pediatric patients.
Method: The consecutive 250 eligible pediatric patients aged between 6 months- 12 years with ASA risk score of I-II undergoing surgery lasting less than four hours were enrolled the study in six months period. Patient demographics, procedure, preoperative fasting time, preoperative and postoperative glucose levels were documented. Lactate ringer (LR) solution with % 2 glucose was infused to the patients with preoperative blood glucose level lower than 60 mg/dL, LR solution with % 1 glucose was used for the patients with preoperative blood glucose level between 60-90 mg/dL, LR solution without glucose was used for the patients with preoperative blood glucose level higher than 90 mg/dL.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Glucose Levels in Children During Anesthesia
NCT06915493
Intravenous Bolus-infusion Versus Sliding Scale of Insulin for Intra-operative Glycemic Control
NCT05136157
Perioperative Versus Postoperative Glycemia Control in Cardiac Surgery Patients
NCT01548963
Associated Factors in Perioperative Hypoglycemia in Patients With Diabetes
NCT00826007
SPECS: Safe Pediatric Euglycemia in Cardiac Surgery
NCT00443599
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2% Dextrose infusion group
Drug:LR+ 2 % Dextrose infusion Lactate ringer (LR) solution with % 2 glucose; the patients with preoperative blood glucose level lower than 60 mg/dL,
Drug: dextrose containing infusion
Drug: infusing dextrose containing or non glucose fluid according to blood glucose level
Drug:1% Dextrose infusion group
Drug:LR+ 1% Dextrose infusion LR solution with % 1 glucose: the patients with preoperative blood glucose level between 60-90 mg/dL,
Drug: dextrose containing infusion
Drug: infusing dextrose containing or non glucose fluid according to blood glucose level
non glucose infusion group
Drug: LR infusion LR solution without glucose; the patients with preoperative blood glucose level higher than 90 mg/dL.
Drug: dextrose containing infusion
Drug: infusing dextrose containing or non glucose fluid according to blood glucose level
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Drug: dextrose containing infusion
Drug: infusing dextrose containing or non glucose fluid according to blood glucose level
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergoing surgery lasting less than four hours were enrolled the study
Exclusion Criteria
* Parenteral nutrition or enteral nutrition
* Patient with metabolic disorders,
* ASA III-IV patients
6 Months
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayse Cigdem Tutuncu
Assoc Prof
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
82546
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.